Summary
Eli Lilly said the response for its blockbuster drug Mounjaro has been “positive” in India, adding that it is focusing on meeting demand for the drug in the world’s most populous country.
Source: Reuters on MSN.com
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
